1. Home
  2. HOWL vs LEE Comparison

HOWL vs LEE Comparison

Compare HOWL & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • LEE
  • Stock Information
  • Founded
  • HOWL 2017
  • LEE 1890
  • Country
  • HOWL United States
  • LEE United States
  • Employees
  • HOWL N/A
  • LEE N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • HOWL Health Care
  • LEE Consumer Discretionary
  • Exchange
  • HOWL Nasdaq
  • LEE Nasdaq
  • Market Cap
  • HOWL 87.4M
  • LEE 90.6M
  • IPO Year
  • HOWL 2021
  • LEE N/A
  • Fundamental
  • Price
  • HOWL $1.28
  • LEE $11.99
  • Analyst Decision
  • HOWL Strong Buy
  • LEE
  • Analyst Count
  • HOWL 2
  • LEE 0
  • Target Price
  • HOWL $9.50
  • LEE N/A
  • AVG Volume (30 Days)
  • HOWL 263.3K
  • LEE 30.5K
  • Earning Date
  • HOWL 03-06-2025
  • LEE 02-06-2025
  • Dividend Yield
  • HOWL N/A
  • LEE N/A
  • EPS Growth
  • HOWL N/A
  • LEE N/A
  • EPS
  • HOWL N/A
  • LEE N/A
  • Revenue
  • HOWL $3,386,000.00
  • LEE $600,264,000.00
  • Revenue This Year
  • HOWL N/A
  • LEE N/A
  • Revenue Next Year
  • HOWL $34.17
  • LEE N/A
  • P/E Ratio
  • HOWL N/A
  • LEE N/A
  • Revenue Growth
  • HOWL N/A
  • LEE N/A
  • 52 Week Low
  • HOWL $1.26
  • LEE $7.57
  • 52 Week High
  • HOWL $8.19
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • LEE 36.69
  • Support Level
  • HOWL $1.26
  • LEE $11.87
  • Resistance Level
  • HOWL $1.45
  • LEE $13.69
  • Average True Range (ATR)
  • HOWL 0.09
  • LEE 0.92
  • MACD
  • HOWL 0.02
  • LEE 0.01
  • Stochastic Oscillator
  • HOWL 45.45
  • LEE 19.18

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: